RecruitingNot Applicable

Minimally Invasive Treatments of the Thyroid

Italy270 participantsStarted 2022-10-10

Plain-language summary

This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Thyroid MicroCarcinoma (PTMC)

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients \> 18years * Patients with diagnosis of papillary thyroid microcarcinoma, citologically proven, suitable for MITT. * Written informed consent must be signed and dated by the patient and the investigator prior to inclusion. * Patients must be accessible for follow-up Exclusion Criteria: * Tumors \> 1 cm, other citological type, refusal of MITT, unsuitable for MITT, unmanageable coagulative disorders * Patients with psychiatric, addictive, or any disorder, which compromises ability to give informed consent for participation in this study

What they're measuring

The proportion of patients with major complications occurring within one month after the date of intervention

Timeframe: 1 month

Trial details

NCT IDNCT06333587

SponsorEuropean Institute of Oncology

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-31

Contact for this trial

Giovanni Mauri

+390294372691 giovanni.mauri@ieo.it

View on ClinicalTrials.gov More Papillary Thyroid Microcarcinoma trials